相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Treatment of health-care-associated infections caused by Gram-negative bacteria: a consensus statement
Ian Chopra et al.
LANCET INFECTIOUS DISEASES (2008)
Current concepts: Acinetobacter infection
L. Silvia Munoz-Price et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Extension of the hydrolysis spectrum of AmpC β-lactamase of Escherichia coli due to amino acid insertion in the H-10 helix
Hedi Mammeri et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
New plasmid-mediated fluoroquinolone efflux pump, QepA, found in an Eschefichia coli clinical isolate
Kunikazu Yamane et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Genetic and biochemical characterization of GES-5, an extended-spectrum class A β-lactamase from Klebsiella pneumoniae
Il Kwon Bae et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2007)
Anti-infective research and development - problems, challenges, and solutions
John S. Bradley et al.
LANCET INFECTIOUS DISEASES (2007)
The business of developing antibacterials
Jeffrey L. Fox
NATURE BIOTECHNOLOGY (2006)
Characterization of the bifunctional aminoglycoside-modifying enzyme ANT(3)-Ii/AAC(6′)-IId from Serratia marcescens
Choonkeun Kim et al.
BIOCHEMISTRY (2006)
Naturally occurring extended-spectrum cephalosporinases in Escherichia coli
Hedi Mammeri et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
The future should not look like the past
[Anonymous]
LANCET INFECTIOUS DISEASES (2006)
Structural basis for the extended substrate spectrum of CMY-10, a plasmid-encoded class C β-lactamase
JY Kim et al.
MOLECULAR MICROBIOLOGY (2006)
Horizontal transfer of blaCMY-bearing plasmids among clinical Escherichia coli and Klebsiella pneumoniae isolates and emergence of cefepime-hydrolyzing CMY-19
J Wachino et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase
A Robicsek et al.
NATURE MEDICINE (2006)
The threat of antibiotic resistance in Gram-negative pathogenic bacteria:: β-lactams in peril!
JM Thomson et al.
CURRENT OPINION IN MICROBIOLOGY (2005)
Extended-spectrum β-lactamases:: a clinical update
DL Paterson et al.
CLINICAL MICROBIOLOGY REVIEWS (2005)
Resistance to ceftazidime is associated with a S220Y substitution in the omega loop of the AmpC β-lactamase of a Serratia marcescens clinical isolate
N Hidri et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)
Selection during cefepime treatment of a new cephalosporinase variant with extended-spectrum resistance to cefepime in an Enterobacter aerogenes clinical isolate
G Barnaud et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Resistance to cefepime and cefpirome due to a 4-amino-acid deletion in the chromosome-encoded AmpC β-lactamase of a Serratia marcescens clinical isolate
H Mammeri et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Inhibitor-sensitive AmpC β-lactamase variant produced by an Escherichia coli clinical isolate resistant to oxyiminocephalosporins and cephamycins
Y Doi et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
AmpC β-lactamase in an Escherichia coli clinical isolate confers resistance to expanded-spectrum cephalosporins
H Mammeri et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
The process of structure-based drug design
AC Anderson
CHEMISTRY & BIOLOGY (2003)
AmpC β-lactamases:: what do we need to know for the future?
ND Hanson
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2003)
Emergence in Klebsiella pneumoniae of a chromosome-encoded SHV β-lactamase that compromises the efficacy of imipenem
L Poirel et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Biochemical analysis of the ceftazidime-hydrolysing extended-spectrum β-lactamase CTX-M-15 and of its structurally related β-lactamase CTX-M-3
L Poirel et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2002)
Structure-based discovery of a novel, noncovalent inhibitor of AmpC β-lactamase
RA Powers et al.
STRUCTURE (2002)
Mutational replacement of Leu-293 in the class C Enterobacter cloacae P99 β-lactamase confers increased MIC of cefepime
SB Vakulenko et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Mutation in Serratia marcescens AmpC β-lactamase producing high-level resistance to ceftazidime and cefpirome
A Raimondi et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Controversies about extended-spectrum and AmpC beta-lactamases
KS Thomson
EMERGING INFECTIOUS DISEASES (2001)
Version 2000:: the new β-lactamases of gram-negative bacteria at the dawn of the new millennium
KS Thomson et al.
MICROBES AND INFECTION (2000)
分享论文
